A 14,000-patient trial has shown that LDL cholesterol reduction with the non-statin therapy translates to a lower rate of cardiovascular death, heart attack, stroke or revascularization.
Statin Intolerance and New Lipid-Lowering Treatments
This brief review shares a pragmatic road map for managing atherosclerosis in patients who cannot or will not take a statin. And it looks ahead to new statin alternatives on the horizon.
Two Reasons Why LDL Cholesterol Management Isn’t as Settled as You May Think
Our experts review real-world strategies for patients with statin intolerance and an anticipated new therapy that doesn’t cause muscle symptoms.
No. 8 Medical Innovation for 2020: Bempedoic Acid for Statin-Intolerant Patients
Bempedoic acid for statin-intolerant patients will be the No. 8 most influential medical innovation for 2020, predict experts at Cleveland Clinic.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy